$DDD earnings report

3D Systems Reports Third Quarter 2026 Financial Results. AlphAI read 3D Systems's Q3 FY2026 filing as mixed. 2 quarters are on record below.

Q3 FY2026

AlphAI · Earnings readDDD · Q3 2026 · ended September 30, 2026

3D Systems Reports Third Quarter 2026 Financial Results

→Mixed quarter

Revenue, gross margin and Adjusted EBITDA improved, with Adjusted EBITDA turning positive, but the Company reported a wider net loss, negative operating cash flow for the first nine months, and guided to Adjusted EBITDA of ($2) million - $0 million in the fourth quarter.

Revenue
$99.3M
8.8% y/y
Q3 2026 Healthcare Solutions
$49M
approximately 14.4% y/y
EPS · non-GAAP
$(0.06)
Fourth Quarter 2026 outlook
$100 - $103 million

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Q3 2026 total revenueGAAP$99.3M–8.8%
Q3 2026 products revenueGAAP$58,178––
Q3 2026 services revenueGAAP$41,126––
Q3 2026 revenue excluding software divestituresnon-GAAP$99.3M–10.9%
Q3 2026 gross profitGAAP$34.8M––
Q3 2026 gross profit marginGAAP35.0%––
Q3 2026 non-GAAP gross profitnon-GAAP$35.2M––
Q3 2026 non-GAAP gross profit marginnon-GAAP35.5%––
Q3 2026 non-GAAP gross profit margin excluding software divestituresnon-GAAP35.5%–420 basis points
Q3 2026 operating expensesGAAP$59.3M––
Q3 2026 non-GAAP operating expenses excluding software divestituresnon-GAAP$36.1M––
Q3 2026 operating lossGAAP−$24.5M––
Q3 2026 net loss attributable to 3D Systems CorporationGAAP−$33.5M–increased by $15.5 million
Q3 2026 diluted loss per shareGAAP$(0.21)––
Q3 2026 non-GAAP diluted loss per share excluding software divestituresnon-GAAP$(0.06)––
Q3 2026 Adjusted EBITDAnon-GAAP$3.1M––
Q3 2026 Adjusted EBITDA excluding software divestituresnon-GAAP$3.1M–improved $13.1 million
Nine months 2026 total revenueGAAP$289.4M––
Nine months 2026 products revenueGAAP$170,788––
Nine months 2026 services revenueGAAP$118,633––
Nine months 2026 revenue excluding software divestituresnon-GAAP$289.4M––
Nine months 2026 gross profitGAAP$103.6M––
Nine months 2026 gross profit marginGAAP35.8%––
Nine months 2026 non-GAAP gross profit margin excluding software divestituresnon-GAAP36.1%––
Nine months 2026 operating expensesGAAP$145.4M––
Nine months 2026 non-GAAP operating expenses excluding software divestituresnon-GAAP$112.2M––
Nine months 2026 operating lossGAAP−$41.8M––
Nine months 2026 net loss attributable to 3D Systems CorporationGAAP−$50.8M––
Nine months 2026 diluted loss per shareGAAP$(0.33)––
Nine months 2026 non-GAAP diluted loss per share excluding software divestituresnon-GAAP$(0.11)––
Nine months 2026 Adjusted EBITDA excluding software divestituresnon-GAAP$4.4M––

Segments

SegmentRevenueq/qy/y
Q3 2026 Healthcare SolutionsHigher dental material sales and increased parts manufacturing volumes.$49M–approximately 14.4%
Q3 2026 Industrial SolutionsHigher printer and parts manufacturing sales; revenue increased 7.7% excluding the impact of software divestitures.$50.3M–approximately 3.9%
Nine months 2026 Healthcare SolutionsThe Company said its four strategic markets delivered strong double-digit growth through the first three quarters of 2026.$147.2M––
Nine months 2026 Industrial SolutionsThe Company said its four strategic markets delivered strong double-digit growth through the first three quarters of 2026.$142.2M––

Fourth Quarter 2026 outlook

  • Revenue$100 - $103 million
  • NoteAdjusted EBITDA: ($2) million - $0 million
  • NoteAt the midpoint of its fourth-quarter outlook, the Company expects full year revenue growth approaching mid-single digits for 2026.

Capital returns

  • Stock repurchases: —
  • Proceeds from equity offering: $53,825
  • Purchase of non-controlling interests: $(900)
  • Taxes paid related to net-share settlement of equity awards: $(879)

What drove it

  • Q3 revenue growth was driven by double-digit growth in new printer and parts manufacturing sales and strong dental materials revenue.
  • Healthcare growth was driven by continued growth in personalized healthcare solutions, including more than 20% growth in healthcare parts manufacturing and dental materials sales.
  • Industrial performance reflected strong growth in Data Center Infrastructure and more than 50% growth in Aerospace & Defense.
  • Non-GAAP gross profit margin benefited from higher printer and parts-manufacturing volumes, product gross profit margin expansion, and the non-recurrence of certain prior-year costs associated with a non-core site closure and a Reg Med accounting adjustment.
  • Adjusted EBITDA improvement reflected prior cost reduction initiatives, higher sales volumes and improved operating leverage.

Concerns

  • Q3 net loss attributable to 3D Systems Corporation was $(33.5) million, compared with $(18.1) million in the prior-year period.
  • The increased net loss was primarily attributed to litigation expense, an asset impairment charge, an unfavorable foreign exchange impact, and an unfavorable year-over-year change in income taxes.
  • Q3 asset impairment charges were $2,857.
  • Q3 foreign exchange loss, net was $(6,294), compared with foreign exchange gain, net of $2,623 in the prior-year period.
  • Nine months 2026 net cash used in operating activities was $(17,502).
  • The fourth-quarter outlook calls for Adjusted EBITDA of ($2) million - $0 million.
  • The outlook incorporates normal variability in customer program and investment cycles and more evenly distributed purchasing patterns observed throughout the year.
  • The Company cited a volatile broader economic and geopolitical environment.

What to watch

  • Execution against fourth-quarter revenue guidance of $100 - $103 million.
  • Whether fourth-quarter Adjusted EBITDA falls within the guided range of ($2) million - $0 million after Q3 Adjusted EBITDA of $3.1 million.
  • Continued demand in Med Tech, Dental, Aerospace & Defense and Data Center Infrastructure.
  • Customer program and investment-cycle variability and purchasing patterns.
  • Cash usage, including operating cash flow and purchases of property and equipment.
  • The $3.9 million in principal debt scheduled to mature in the fourth quarter of 2026.

Balance sheet and cash flow

  • At September 30, 2026, total cash and investments were $120.5 million.
  • Cash, cash equivalents and restricted cash were $91.8 million.
  • Short-term investments were $27.1 million.
  • Long-term investments were $1.6 million.
  • Current portion of long-term debt, net of deferred financing costs, was $3,944.
  • Long-term debt, net of deferred financing costs, was $87,852.
  • $3.9 million in principal amount of debt is scheduled to mature in the fourth quarter of 2026, with the remaining $92.0 million principal maturing in 2030.
  • Nine months 2026 net cash used in operating activities was $(17,502).
  • Nine months 2026 purchases of property and equipment were $(8,315).
  • Nine months 2026 net cash used in investing activities was $(37,918).
  • Nine months 2026 net cash provided by financing activities was $50,108.
  • Cash, cash equivalents and restricted cash at the end of the period was $91,766.

Analysis

Third-quarter revenue was $99.3 million, compared with $91.2 million in the prior-year period, with growth led by Healthcare Solutions revenue of $49.0 million and Industrial Solutions revenue of $50.3 million. Healthcare growth was tied to dental materials and parts manufacturing volumes. Industrial growth reflected higher printer and parts manufacturing sales, with Data Center Infrastructure and Aerospace & Defense identified as key contributors. Revenue excluding software divestitures was $99.3 million, compared with $89.5 million in the prior-year period.

Profitability improved at the gross-profit and adjusted EBITDA levels. GAAP gross profit margin was 35.0%, compared with 32.3%, while non-GAAP gross profit margin excluding software divestitures was 35.5%, compared with 31.3%. The Company attributed the improvement to printer and parts-manufacturing volumes, product gross-profit expansion and the absence of specified prior-year costs. Adjusted EBITDA excluding software divestitures was $3.1 million, compared with $(10.0) million, supported by cost actions, higher volume and operating leverage.

GAAP earnings remained pressured. Net loss attributable to 3D Systems Corporation was $(33.5) million, compared with $(18.1) million, and diluted loss per share was $(0.21), compared with $(0.14). Management cited litigation expense, an asset impairment charge, unfavorable foreign exchange and an unfavorable year-over-year change in income taxes. Q3 operating loss was $(24.5) million, compared with $(21.3) million, despite the improvement in non-GAAP operating expenses excluding software divestitures to $36.1 million from $42.3 million.

For the first nine months, revenue was $289.4 million and Adjusted EBITDA excluding software divestitures was $4.4 million, compared with $(40.8) million. However, net cash used in operating activities was $(17,502), and the Company ended the period with total cash and investments of $120.5 million. It also raised $53,825 through an equity offering during the nine-month period.

Fourth-quarter guidance calls for revenue of $100 - $103 million and Adjusted EBITDA of ($2) million - $0 million. Management described continued momentum in its four strategic markets but incorporated customer-program and investment-cycle variability and more evenly distributed purchasing patterns. The guide points to a return to negative or breakeven adjusted EBITDA following the positive third quarter, making demand conversion, operating leverage and cash usage central items for the next report.

Management, verbatim

We are pleased with our third-quarter and year-to-date performance. Revenue growth accelerated, Adjusted EBITDA turned positive for the quarter and the year-to-date period, and our four strategic markets, Med Tech, Dental, Aerospace & Defense, and Data Center Infrastructure, continued to deliver strong double-digit growth.

Dr. Jeffrey Graves, President and Chief Executive Officer of 3D Systems

As the additive manufacturing industry begins to emerge from a multi-year downturn, the consistent investments we have made in technology, application expertise, and production capacity during this challenging period have positioned the Company to benefit from the recovery.

Dr. Jeffrey Graves, President and Chief Executive Officer of 3D Systems

We delivered strong revenue growth while maintaining effective cost management, resulting in positive Adjusted EBITDA year-to-date.

Phyllis Nordstrom, Chief Financial Officer of 3D Systems

Not in the filing

stated, not guessed
  • Previous-quarter financial metrics and sequential comparisons were not provided.
  • Free cash flow was not reported.
  • Dividend information was not reported.
  • A quantitative fourth-quarter GAAP earnings, GAAP operating income, GAAP EPS, gross-margin, operating-expense or tax-rate outlook was not provided.
  • Prior-period guidance was not provided, so no comparison of actual results with prior guidance is available.
  • A quantitative year-over-year change was not printed for several reported financial statement line items, including gross profit, operating expenses, operating loss, EPS and nine-month metrics.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Q2 FY2026

AlphAI · Earnings readDDD · Q2 2026 · ended June 30, 2026

3D Systems Reports Second Quarter 2026 Financial Results

→Mixed quarter

Revenue was $94.6 million, down 0.3% year-over-year on a GAAP basis, while Healthcare Solutions grew approximately 6.8% and Industrial Solutions declined approximately 6.7%. Cost reductions improved Adjusted EBITDA to a loss of $(0.8) million, but gross margin declined and the company reported a GAAP net loss of $(12.9) million.

Revenue
$94.6M
down 0.3% year-over-year y/y
Q2 2026 Healthcare Solutions
$48.1M
increased approximately 6.8% y/y
EPS · non-GAAP
$(0.04)
Third Quarter 2026 outlook
$96 - $99 million

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Q2 2026 total revenueGAAP$94.6M–down 0.3% year-over-year
Q2 2026 products revenueGAAP$54.84M––
Q2 2026 services revenueGAAP$39.74M––
Q2 2026 gross profitGAAP$34.5M––
Q2 2026 gross profit marginGAAP36.4%––
Q2 2026 operating expenseGAAP$45.1M––
Q2 2026 operating lossGAAP−$10.6M––
Q2 2026 net loss attributable to 3D Systems CorporationGAAP−$12.9M–decreased by $117.3 million
Q2 2026 diluted loss per shareGAAP$(0.09)––
Q2 2026 basic loss per shareGAAP$(0.09)––
Q2 2026 revenue excluding software divestituresnon-GAAP$94.6M–increased 1.4%
Q2 2026 gross profit excluding software divestituresnon-GAAP$34.7M––
Q2 2026 gross profit margin excluding software divestituresnon-GAAP36.7%–decreased by 150 basis points
Q2 2026 non-GAAP operating expense excluding software divestituresnon-GAAP$39.5M––
Q2 2026 Adjusted EBITDA excluding software divestituresnon-GAAP−$800K–improved by $4.6 million
Q2 2026 non-GAAP diluted loss per share excluding software divestituresnon-GAAP$(0.04)––
First half 2026 total revenueGAAP$190.1M––
First half 2026 gross profitGAAP$68.8M––
First half 2026 gross profit marginGAAP36.2%––
First half 2026 operating expenseGAAP$86.1M––
First half 2026 operating lossGAAP−$17.3M––
First half 2026 net loss attributable to 3D Systems CorporationGAAP−$17.3M––
First half 2026 diluted loss per shareGAAP$(0.12)––
First half 2026 revenue excluding software divestituresnon-GAAP$190.1M–increased 6%
First half 2026 gross profit margin excluding software divestituresnon-GAAP36.4%––
First half 2026 non-GAAP operating expense excluding software divestituresnon-GAAP$76.1M––
First half 2026 Adjusted EBITDA excluding software divestituresnon-GAAP$1.3M––
First half 2026 non-GAAP diluted loss per share excluding software divestituresnon-GAAP$(0.05)––

Segments

SegmentRevenueq/qy/y
Q2 2026 Healthcare SolutionsHigher sales of new printer systems in Med Tech and continued growth in Personalized Healthcare Services.$48.1M–increased approximately 6.8%
Q2 2026 Industrial SolutionsHigher product sales and over 20% growth in Aerospace & Defense and Data Center Infrastructure were offset by the absence of revenue from a non-core product offering exited in the prior year and lower hardware services revenue.$46.5Mincreasing 2.4% sequentiallydecreased approximately 6.7%; decreased 3.7% year over year adjusting for divestitures
First half 2026 Healthcare SolutionsThe release identified Med Tech and Dental as priority Healthcare markets.$98.2M––
First half 2026 Industrial SolutionsThe release identified Aerospace & Defense and Data Center Infrastructure as priority Industrial markets.$91.9M––

Third Quarter 2026 outlook

  • Revenue$96 - $99 million
  • NoteAdjusted EBITDA: ($3) million - ($1) million

What drove it

  • Continued acceleration of new printer sales, with double-digit growth in both metal and polymer hardware printer systems.
  • Healthcare revenue was supported by over 20% growth in Med Tech and 3% growth in Dental.
  • The four priority markets, Med Tech, Dental, Aerospace & Defense, and Data Center Infrastructure, all delivered more than 20% growth in the first half of 2026.
  • Gross profit was partially offset by approximately $2.6 million of tariff refunds recovered in the quarter.
  • Adjusted EBITDA improved primarily from prior cost reduction initiatives and tariff refunds recovered in the quarter.

Concerns

  • GAAP revenue decreased 0.3% year-over-year to $94.6 million.
  • Industrial Solutions revenue decreased approximately 6.7% year-over-year, or 3.7% excluding divestitures.
  • GAAP gross profit margin decreased to 36.4% from 38.1%, reflecting product mix, higher printer sales and select pricing impacts.
  • The Company reported a GAAP net loss of $(12.9) million and guided Adjusted EBITDA to a range of ($3) million - ($1) million for the third quarter of 2026.
  • Management said the global economic environment remains uncertain.

What to watch

  • Execution against third quarter 2026 revenue guidance of $96 - $99 million.
  • Third quarter 2026 Adjusted EBITDA guidance of ($3) million - ($1) million.
  • Whether new printer systems continue to support growth in metal and polymer hardware printer systems.
  • Sustainability of growth in Med Tech, Dental, Aerospace & Defense, and Data Center Infrastructure.
  • Gross-margin progression following the quarter's product-mix effects, select pricing impacts and approximately $2.6 million of tariff refunds.

Balance sheet and cash flow

  • At June 30, 2026, total cash was $129.0 million, including cash and cash equivalents of $128.0 million and restricted cash of $1.0 million.
  • Cash and cash equivalents were $127,951 (in thousands) at June 30, 2026, compared with $95,635 (in thousands) at December 31, 2025.
  • During the second quarter 2026, the Company issued 18.9 million shares of common stock for $53.2 million in cash, net of offering costs.
  • Net cash used in operating activities was $(14,106) thousand for the six months ended June 30, 2026, compared with $(59,630) thousand for the six months ended June 30, 2025.
  • Purchases of property and equipment were $(5,890) thousand for the six months ended June 30, 2026, compared with $(5,743) thousand for the six months ended June 30, 2025.
  • Net cash provided by financing activities was $51,942 thousand for the six months ended June 30, 2026, compared with net cash used in financing activities of $(97,340) thousand for the six months ended June 30, 2025.
  • A total of $3.9 million in principal amount of debt is scheduled to mature in the fourth quarter of 2026, with the remaining $92.0 million principal maturing in 2030.
  • Current portion of long-term debt, net of deferred financing costs, was $3,944 (in thousands), and long-term debt, net of deferred financing costs, was $87,240 (in thousands), at June 30, 2026.

Analysis

Second-quarter revenue was $94.6 million, down 0.3% year-over-year on a GAAP basis. Excluding software divestitures, revenue was $94.6 million versus $93.3 million and increased 1.4%. The revenue profile was split between Healthcare Solutions, which increased approximately 6.8% to $48.1 million, and Industrial Solutions, which decreased approximately 6.7% to $46.5 million. Industrial revenue increased 2.4% sequentially, while the release attributed the year-over-year decline in part to the exit of a non-core product offering and lower hardware services revenue.

Demand commentary centered on new printer systems and the four priority markets. The company cited double-digit growth in both metal and polymer hardware printer systems, more than 20% growth in Med Tech, Aerospace & Defense and Data Center Infrastructure, and 3% growth in Dental. Healthcare growth was tied to new Med Tech printer sales and Personalized Healthcare Services. Industrial performance benefited from higher product sales and growth in Aerospace & Defense and Data Center Infrastructure, but those strengths did not offset the reported year-over-year Industrial decline.

Profitability improved at the operating level but gross margin contracted. GAAP gross profit margin was 36.4%, compared with 38.1% in the prior-year period. Non-GAAP gross profit margin excluding software divestitures was 36.7%, compared with 38.2%, a decrease of 150 basis points. The company cited product mix from higher printer sales and select pricing impacts, partially offset by approximately $2.6 million of tariff refunds. GAAP operating loss narrowed to $(10.6) million from $(15.4) million, while non-GAAP operating expense excluding software divestitures declined to $39.5 million from $44.6 million.

GAAP net loss attributable to 3D Systems Corporation was $(12.9) million, compared with income of $104.4 million in the prior-year period. The company said the decline primarily reflected the prior-year gain on the sale of Geomagic and gain on debt extinguishment, partially offset by improved operating margins and a lower income tax provision. Adjusted EBITDA excluding software divestitures improved to a loss of $(0.8) million from a loss of $(4.7) million. For the first half, Adjusted EBITDA excluding software divestitures was positive $1.3 million, compared with $(30.8) million.

Liquidity increased after the company issued 18.9 million shares for $53.2 million in cash, net of offering costs. Total cash was $129.0 million at June 30, 2026, while $3.9 million of principal debt is scheduled to mature in the fourth quarter of 2026 and $92.0 million in 2030. Net cash used in operating activities for the first half was $(14,106) thousand. For the third quarter, management guided revenue to $96 - $99 million and Adjusted EBITDA to ($3) million - ($1) million, framing continued revenue growth alongside an expected adjusted EBITDA loss.

Management, verbatim

We are pleased with our second-quarter and first-half performance on both the top and bottom line. Revenue growth was driven by strength in our four key markets: Med Tech and Dental in Healthcare, and Aerospace & Defense and Data Center Infrastructure in Industrial.

Dr. Jeffrey Graves, President and Chief Executive Officer of 3D Systems

As the additive manufacturing industry continues to emerge from a multi-year downturn, our sustained investments in research and development are now enabling us to introduce a broad portfolio of new products that are gaining increasing customer traction.

Dr. Jeffrey Graves, President and Chief Executive Officer of 3D Systems

Adjusting for divestitures completed in 2025, total revenue increased 1.4% year over year and 6% for the first half of 2026, demonstrating continued core revenue growth in the year

Phyllis Nordstrom, Chief Financial Officer of 3D Systems

Not in the filing

stated, not guessed
  • Previous-release outlook was not provided, so no comparison of actual results with prior guidance is available.
  • Prior-quarter comparative values were not reported for the consolidated financial metrics, except that Industrial revenue was stated to be increasing 2.4% sequentially.
  • Free cash flow was not reported.
  • Quarterly operating cash flow and quarterly capital expenditures were not reported.
  • Dividend information was not reported.
  • Third quarter 2026 guidance for gross margin, operating expenses and tax rate was not reported.
  • A quantitative GAAP reconciliation for forward-looking Adjusted EBITDA was not provided.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about DDD earnings dates

When is 3D Systems's next earnings date?
AlphAI has no date for DDD yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.